RTW Biotech Opportunities

Last updated

RTW Biotech Opportunities
Industry Investment trust
Founded2019;6 years ago (2019)
Headquarters
London, United Kingdom
Website www.rtwfunds.com/rtw-biotech-opportunities-ltd/

RTW Biotech Opportunities is a large British investment trust focused on investments in the biotechnology industry. The company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. [1]

Contents

History

Established in 2019, the company invests in companies at all stages of development from the early stages of testing to full production of pharmaceuticals. [2] Work by the administration of President Donald Trump to reach agreement with pharmaceutical companies over drug prices and tariffs, together with renewed mergers & acquisitions activity in the sector, led to renewed interest in the sector, and the company in particular, in the second half of 2025. [3] [4] The company is managed by RTW Investments and the chairman is William Simpson. [5]

References

  1. ↑ "Spectris (UK): Constituent Deletion – Update Changes in FTSE UK Index Series". FTSE Russell. 1 December 2025. Retrieved 1 December 2025.
  2. ↑ "This trust buys shares that can double in a day or be wiped out. The risk could be worth it". The Telegraph. 19 June 2025. Retrieved 1 December 2025.
  3. ↑ "Saba puts fresh capital into RTW Biotech's rally (and lifts Smithson stake to 16%)". Quoted Data. 5 November 2025. Retrieved 1 December 2025.
  4. ↑ "Biotech trusts regain ground after M&A revival". Investors Chronicle. 20 October 2025. Retrieved 1 December 2025.
  5. ↑ "RTW Biotech Opportunities NAV falls in 'volatile' period for biotech". Shares Magazine. 11 September 2025. Retrieved 1 December 2025.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.